{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:56:59Z","timestamp":1782143819489,"version":"3.54.5"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000625","name":"Great Britain Sasakawa Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.autrev.2016.02.011","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T18:49:19Z","timestamp":1455389359000},"page":"552-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Autoantibody pain"],"prefix":"10.1016","volume":"15","author":[{"given":"Andreas","family":"Goebel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2016.02.011_bb0005","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0895-4356(00)00204-3","article-title":"Which chronic conditions are associated with better or poorer quality of life?","volume":"53","author":"Sprangers","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.autrev.2016.02.011_bb0010","doi-asserted-by":"crossref","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","author":"Treede","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.02.011_bb0015","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s11892-014-0538-5","article-title":"The role of sodium channels in painful diabetic and idiopathic neuropathy","volume":"14","author":"Lauria","year":"2014","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.autrev.2016.02.011_bb0020","unstructured":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:743-800."},{"key":"10.1016\/j.autrev.2016.02.011_bb0025","series-title":"Chronic Pain Epidemiology","author":"Croft","year":"2010"},{"key":"10.1016\/j.autrev.2016.02.011_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/2049463713493264","article-title":"Chronic pain epidemiology \u2014 where do lifestyle factors fit in?","volume":"7","author":"van Hecke","year":"2013","journal-title":"Br J Pain"},{"key":"10.1016\/j.autrev.2016.02.011_bb0035","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/01.brs.0000167536.60002.87","article-title":"Three-year incidence of low back pain in an initially asymptomatic cohort: clinical and imaging risk factors","volume":"30","author":"Jarvik","year":"2005","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.autrev.2016.02.011_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: a generator of pain hypersensitivity by central neural plasticity","author":"Latremoliere","year":"2009","journal-title":"J Pain"},{"key":"10.1016\/j.autrev.2016.02.011_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/msj.21286","article-title":"Preventing post-thoracotomy pain syndrome","volume":"79","author":"Khelemsky","year":"2012","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.autrev.2016.02.011_bb0050","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0165-6147(00)01502-9","article-title":"NK1 (substance P) receptor antagonists\u2014why are they not analgesic in humans?","volume":"21","author":"Hill","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.autrev.2016.02.011_bb0055","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1213\/ANE.0b013e3181cde882","article-title":"The development of new analgesics over the past 50 years: a lack of real breakthrough drugs","volume":"110","author":"Kissin","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.autrev.2016.02.011_bb0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2016.02.011_bb0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nm.2710","article-title":"Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity","volume":"18","author":"Sorge","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2016.02.011_bb0070","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2016.02.011_bb0075","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain\u2013Barre syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2016.02.011_bb0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrneurol.2014.129","article-title":"Pain in neuromyelitis optica\u2014prevalence, pathogenesis and therapy","volume":"10","author":"Bradl","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2016.02.011_bb0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nn.3602","article-title":"Regulating excitability of peripheral afferents: emerging ion channel targets","volume":"17","author":"Waxman","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.autrev.2016.02.011_bb0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/08916930903555943","article-title":"Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction","volume":"43","author":"Gomez","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2016.02.011_bb0095","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.pain.2011.06.012","article-title":"Autoimmunity against the beta(2) adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome","volume":"152","author":"Kohr","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.autrev.2016.02.011_bb0100","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1474-4422(14)70024-9","article-title":"Painful and painless channelopathies","volume":"13","author":"Bennett","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2016.02.011_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/ana.21692","article-title":"Is reflex sympathetic dystrophy\/complex regional pain syndrome type I a small-fiber neuropathy?","author":"Oaklander","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.02.011_bb0110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pain.2013.10.011","article-title":"A CRPS-IgG-transfer-trauma model reproducing inflammatory and positive sensory signs associated with complex regional pain syndrome","volume":"155","author":"Tekus","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.autrev.2016.02.011_bb0115","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1084\/jem.181.6.1945","article-title":"How can cryptic epitopes trigger autoimmunity?","volume":"181","author":"Lanzavecchia","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2016.02.011_bb0120","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/rheumatology\/ker202","article-title":"Complex regional pain syndrome in adults","volume":"50","author":"Goebel","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.02.011_bb0125","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.pain.2013.06.039","article-title":"Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months","volume":"154","author":"Lenz","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.autrev.2016.02.011_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2014.01.490","article-title":"Activation of cutaneous immune responses in complex regional pain syndrome","author":"Birklein","year":"2014","journal-title":"J Pain"},{"key":"10.1016\/j.autrev.2016.02.011_bb0135","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/ejp.685","article-title":"Cutaneous immunopathology of long-standing complex regional pain syndrome","volume":"19","author":"Osborne","year":"2015","journal-title":"Eur J Pain"},{"key":"10.1016\/j.autrev.2016.02.011_bb0140","doi-asserted-by":"crossref","DOI":"10.1212\/01.WNL.0000028686.74056.E3","article-title":"Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy","author":"Kemler","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.02.011_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/0140-6736(93)92877-V","article-title":"Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients","author":"Veldman","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2016.02.011_bb0150","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.autrev.2012.10.015","article-title":"Complex regional pain syndrome, prototype of a novel kind of autoimmune disease","volume":"12","author":"Goebel","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.02.011_bb0155","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.pain.2014.09.022","article-title":"Longstanding complex regional pain syndrome is associated with activating autoantibodies against alpha-1a adrenoceptors","volume":"155","author":"Dubuis","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.autrev.2016.02.011_bb0160","series-title":"Immune mediated disturbances of bone, connective tissue and vascular metabolism in Complex Regional Pain Syndrome (CRPS) \u2014 a new pathogenic mechanism of therapeutic relevance","author":"Dharmalingam","year":"2015"},{"key":"10.1016\/j.autrev.2016.02.011_bb0165","article-title":"Effects of serum immunoglobulins from patients with complex regional pain syndrome (CRPS) on depolarisation-induced calcium transients in isolated dorsal root ganglion (DRG) neurons","author":"Reilly","year":"2015","journal-title":"Exp Neurol"},{"key":"10.1016\/j.autrev.2016.02.011_bb0170","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pain.2009.06.023","article-title":"Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1","volume":"145","author":"Sigtermans","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.autrev.2016.02.011_bb0175","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/1745-6215-15-404","article-title":"Low-dose intravenous immunoglobulin treatment for complex regional pain syndrome (LIPS): study protocol for a randomized controlled trial","volume":"15","author":"Goebel","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.autrev.2016.02.011_bb0180","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7326\/0003-4819-152-3-201002020-00006","article-title":"Intravenous immunoglobulin treatment of Complex Regional Pain Syndrome: a randomized trial","volume":"152","author":"Goebel","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2016.02.011_bb0185","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/pme.12601","article-title":"Treatment of long-standing complex regional pain syndrome with therapeutic plasma exchange: a preliminary case series of patients treated in 2008\u20132014","volume":"15","author":"Goebel","year":"2014","journal-title":"Pain Med"},{"key":"10.1016\/j.autrev.2016.02.011_bb0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ejp.572","article-title":"Improvement of complex regional pain syndrome after plasmapheresis","volume":"19","author":"Blaes","year":"2015","journal-title":"Eur J Pain"},{"key":"10.1016\/j.autrev.2016.02.011_bb0195","first-page":"383","article-title":"Plasma exchange therapy in patients with Complex Regional Pain Syndrome","volume":"18","author":"Aradillas","year":"2015","journal-title":"Pain Physician"},{"key":"10.1016\/j.autrev.2016.02.011_bb0200","article-title":"Complex regional pain syndrome and dysautonomia in a 14-year-old girl responsive to therapeutic plasma exchange","author":"Hendrickson","year":"2015","journal-title":"J Clin Apher"},{"key":"10.1016\/j.autrev.2016.02.011_bb0205","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.02.011_bb0210","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.autrev.2012.10.016","article-title":"Developments in autoimmune channelopathies","volume":"12","author":"Vincent","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.02.011_bb0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nrl.2013.12.007","article-title":"Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex","volume":"30","author":"Montojo","year":"2015","journal-title":"Neurologia"},{"key":"10.1016\/j.autrev.2016.02.011_bb0220","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ana.20221","article-title":"Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia","volume":"56","author":"Tomimitsu","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.02.011_bb0225","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2016.02.011_bb0230","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1212\/WNL.0b013e31827040a3","article-title":"Immunotherapy-responsive pain in an abattoir worker with fluctuating potassium channel-complex IgG","volume":"79","author":"Meeusen","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.02.011_bb0235","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.0b013e3182698cab","article-title":"Chronic pain as a manifestation of potassium channel-complex autoimmunity","volume":"79","author":"Klein","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.02.011_bb0240","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.pain.2014.05.025","article-title":"Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations","volume":"155","author":"Gewandter","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.autrev.2016.02.011_bb0245","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group","volume":"121","author":"Fukuda","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2016.02.011_bb0250","series-title":"Medicine Io, ed","article-title":"Beyone Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Redefining an illness","author":"Io","year":"2015"},{"key":"10.1016\/j.autrev.2016.02.011_bb0255","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/M15-0443","article-title":"Diagnostic methods for myalgic encephalomyelitis\/chronic fatigue syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Haney","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2016.02.011_bb0260","first-page":"37","article-title":"Generation of classification criteria for chronic fatigue syndrome using an artificial neural network and traditional criteria set","volume":"16","author":"Linder","year":"2002","journal-title":"In Vivo"},{"key":"10.1016\/j.autrev.2016.02.011_bb0265","doi-asserted-by":"crossref","first-page":"841","DOI":"10.7326\/M15-0114","article-title":"Treatment of myalgic encephalomyelitis\/chronic fatigue syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Smith","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2016.02.011_bb0270","article-title":"Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome","author":"Loebel","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2016.02.011_bb0275","doi-asserted-by":"crossref","first-page":"e26358","DOI":"10.1371\/journal.pone.0026358","article-title":"Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study","volume":"6","author":"Fluge","year":"2011","journal-title":"PloS one"},{"key":"10.1016\/j.autrev.2016.02.011_bb0280","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1073\/pnas.1001074107","article-title":"Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis","volume":"107","author":"Huang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2016.02.011_bb0285","doi-asserted-by":"crossref","first-page":"e0129898","DOI":"10.1371\/journal.pone.0129898","article-title":"B-lymphocyte depletion in myalgic encephalopathy\/chronic fatigue syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment","volume":"10","author":"Fluge","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.02.011_bb0290","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-1085","article-title":"Treatment of primary Sjogren syndrome with rituximab: a randomized trial","volume":"160","author":"Devauchelle-Pensec","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2016.02.011_bb0295","doi-asserted-by":"crossref","DOI":"10.1111\/pme.12319","article-title":"Immunoglobulin G for the treatment of chronic pain: report of an expert workshop","author":"Tamburin","year":"2014","journal-title":"Pain Med"},{"key":"10.1016\/j.autrev.2016.02.011_bb0300","doi-asserted-by":"crossref","DOI":"10.1046\/j.1526-4637.2002.02018.x","article-title":"Human pooled immunoglobulin in the treatment of chronic pain syndromes","author":"Goebel","year":"2002","journal-title":"Pain Med"},{"key":"10.1016\/j.autrev.2016.02.011_bb0305","doi-asserted-by":"crossref","DOI":"10.1126\/science.847460","article-title":"The need for a new medical model: a challenge for biomedicine","author":"Engel","year":"1977","journal-title":"Science"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216300374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216300374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:05:07Z","timestamp":1762553107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216300374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1568997216300374"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.02.011","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibody pain","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}